News

On this episode of Tech Transfer IP, the host interviews Rakhi Gibbons, the Director of Licensing for Tech Launch Arizona at the University of Arizona. Hear about Rakhi and the history, vision and growing successes of TLA.

Botanisol Analytics and Scintillation Nanotechnologies – both founded to commercialize UArizona inventions – have been accepted into the 2021 Flinn Foundation Bioscience Entrepreneurship Program. Each will receive $30,000 in funding through a nonprofit partner, a customized learning plan, and connections with the state’s bioscience leaders in business, research, and policy.

In this podcast Theirry Heles of Global University Venturing interviewed Doug Hockstad, assistant vice-president of Tech Launch Arizona. How has the office has helped drive innovation? How TLA is working to increase diversity? Listen now. 

The National Academy of Inventors (NAI) has named inventors and professors May Khanna and Meredith Hay of the University of Arizona as Senior Members in recognition of their innovative work that has given rise to real impact on the welfare of society. 

Startup GenetiRate has been acquired by biotechnology company IMV Technologies. GenetiRate was founded on a technology that measures the metabolic rate of aquatic animals, from fish to mollusks to crustaceans, to identify and sort out those that grow more quickly, making it useful for the aquaculture industry.

Auxilium Technologies has brought together multiple UArizona inventions that offer sustainable, energy-efficient and cost-effective solutions to improve the output of mines while reducing their environmental impact. 

Technology developed in the Eller College of Management processes several hundred thousand online customer interactions each day, reducing fraud and enhancing the customer experience.

Robert Norwood and Laurence Hurley have been elected as fellows of the academy, the organization's most prestigious designation.

Tech Launch Arizona’s second Student Innovation Challenge has selected five student teams for funding to prototype inventions for commercialization.

UArizona researchers have developed a method of using ketamine in the treatment of Parkinson’s disease. The discovery has been licensed to Pharmather Inc., for development and commercialization.

Researchers have developed a rapid, simplified method for producing radio-labeling compounds used for PET scans.